These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31823411)

  • 1. Pharmacology of mitochondrial permeability transition pore inhibitors.
    Naryzhnaya NV; Maslov LN; Oeltgen PR
    Drug Dev Res; 2019 Dec; 80(8):1013-1030. PubMed ID: 31823411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition.
    Schaller S; Paradis S; Ngoh GA; Assaly R; Buisson B; Drouot C; Ostuni MA; Lacapere JJ; Bassissi F; Bordet T; Berdeaux A; Jones SP; Morin D; Pruss RM
    J Pharmacol Exp Ther; 2010 Jun; 333(3):696-706. PubMed ID: 20215409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Panax quinquefolium saponin attenuates cardiomyocyte apoptosis and opening of the mitochondrial permeability transition pore in a rat model of ischemia/reperfusion.
    Li D; Liu M; Tao TQ; Song DD; Liu XH; Shi DZ
    Cell Physiol Biochem; 2014; 34(4):1413-26. PubMed ID: 25301366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.
    Ikeda G; Matoba T; Nakano Y; Nagaoka K; Ishikita A; Nakano K; Funamoto D; Sunagawa K; Egashira K
    Sci Rep; 2016 Feb; 6():20467. PubMed ID: 26861678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial.
    Le Lamer S; Paradis S; Rahmouni H; Chaimbault C; Michaud M; Culcasi M; Afxantidis J; Latreille M; Berna P; Berdeaux A; Pietri S; Morin D; Donazzolo Y; Abitbol JL; Pruss RM; Schaller S
    J Transl Med; 2014 Feb; 12():38. PubMed ID: 24507657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mitochondrial permeability transition pore and its role in myocardial ischemia reperfusion injury.
    Ong SB; Samangouei P; Kalkhoran SB; Hausenloy DJ
    J Mol Cell Cardiol; 2015 Jan; 78():23-34. PubMed ID: 25446182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opening of mitochondrial permeability transition pore induces hypercontracture in Ca2+ overloaded cardiac myocytes.
    Ruiz-Meana M; Abellán A; Miró-Casas E; Garcia-Dorado D
    Basic Res Cardiol; 2007 Nov; 102(6):542-52. PubMed ID: 17891523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion.
    Gomez L; Paillard M; Thibault H; Derumeaux G; Ovize M
    Circulation; 2008 May; 117(21):2761-8. PubMed ID: 18490522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats.
    Zhang CX; Cheng Y; Liu DZ; Liu M; Cui H; Zhang BL; Mei QB; Zhou SY
    J Nanobiotechnology; 2019 Jan; 17(1):18. PubMed ID: 30683110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the profile of protection afforded by TRO40303 and mild hypothermia in models of cardiac ischemia/reperfusion injury.
    Hansson MJ; Llwyd O; Morin D; de Paulis D; Arnoux T; Gouarné C; Koul S; Engblom H; Bordet T; Tissier R; Arheden H; Erlinge D; Halestrap AP; Berdeaux A; Pruss RM; Schaller S
    Eur J Pharmacol; 2015 Aug; 760():7-19. PubMed ID: 25895640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?
    Hausenloy DJ; Maddock HL; Baxter GF; Yellon DM
    Cardiovasc Res; 2002 Aug; 55(3):534-43. PubMed ID: 12160950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A.
    Onishi A; Miyamae M; Kaneda K; Kotani J; Figueredo VM
    Eur J Pharmacol; 2012 Jan; 675(1-3):40-6. PubMed ID: 22166375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-associated differences in the inhibition of mitochondrial permeability transition pore opening by cyclosporine A.
    Liu L; Zhu J; Brink PR; Glass PS; Rebecchi MJ
    Acta Anaesthesiol Scand; 2011 May; 55(5):622-30. PubMed ID: 21827445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress, mitochondrial permeability transition pore opening and cell death during hypoxia-reoxygenation in adult cardiomyocytes.
    Assaly R; de Tassigny Ad; Paradis S; Jacquin S; Berdeaux A; Morin D
    Eur J Pharmacol; 2012 Jan; 675(1-3):6-14. PubMed ID: 22173126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine-Induced Preconditioning: Involvement of Protein Kinase A and Mitochondrial Permeability Transition Pore.
    Dorsch M; Behmenburg F; Raible M; Blase D; Grievink H; Hollmann MW; Heinen A; Huhn R
    PLoS One; 2016; 11(3):e0151025. PubMed ID: 26968004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARC regulates programmed necrosis and myocardial ischemia/reperfusion injury through the inhibition of mPTP opening.
    Xu T; Ding W; Ao X; Chu X; Wan Q; Wang Y; Xiao D; Yu W; Li M; Yu F; Wang J
    Redox Biol; 2019 Jan; 20():414-426. PubMed ID: 30415165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced cell-volume regulation in cyclosporin A cardioprotection.
    Diaz RJ; Fernandes K; Lytvyn Y; Hawrylyshyn K; Harvey K; Hossain T; Hinek A; Wilson GJ
    Cardiovasc Res; 2013 Jun; 98(3):411-9. PubMed ID: 23483048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotection by the TSPO ligand 4'-chlorodiazepam is associated with inhibition of mitochondrial accumulation of cholesterol at reperfusion.
    Paradis S; Leoni V; Caccia C; Berdeaux A; Morin D
    Cardiovasc Res; 2013 Jun; 98(3):420-7. PubMed ID: 23554458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury.
    Morciano G; Giorgi C; Bonora M; Punzetti S; Pavasini R; Wieckowski MR; Campo G; Pinton P
    J Mol Cell Cardiol; 2015 Jan; 78():142-53. PubMed ID: 25172387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
    Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
    Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.